Page 365 - Haematologica Vol. 109 - July 2024

ERRATUM
Erratum to: Genomic breakpoint-specific monitoring of measurable residual disease in pediatric non-standard risk acute myeloid leukemia
Margarita Maurer-Granofszky,1,2* Stefan Köhrer,1,2* Susanna Fischer,1,2 Angela Schumich,1 Karin Nebral,1,2 Patrizia Larghero,3 Claus Meyer,3 Astrid Mecklenbräuker,1,2 Nora Mühlegger,1 Rolf Marschalek,3 Oskar A. Haas,1 Renate Panzer-Grümayer1 and Michael N. Dworzak1,2,4
1St. Anna Children’s Cancer Research Institute (CCRI), Vienna, Austria; 2Labdia Labordiagnostik, Vienna, Austria; 3Institute of Pharmaceutical Biology/Diagnostic Center of Acute Leukemia (DCAL), Goethe University, Frankfurt/Main, Germany and 4St. Anna Children’s Hospital, Department of Pediatrics, Medical University of Vienna, Vienna, Austria
*MMG and SK contributed equally as first authors.
In the article pre-published online and in the March 2024 issue of Haematologica,1 we have to correct that:
- Since the percentage minimal residual disease for patient 8 was 0.0100 at the first induction timepoint (day 28), the polymerase chain reaction minimal residual disease result should be “positive” instead of “negative” (Page 5, Table 1, P8, Column 6). In the main text on Page 5 the sentence “Three of these samples were positive by gDNA-PCR but below the threshold of 0.1% (Table 1)” should be replaced by “All of these samples were positive by gDNA-PCR but
below the threshold of 0.1% (Table 1).”
- In Table 2, the numbers in column 3 (PCRpos/FCMpos) apply to column 4 (PCRneg/FCMneg) and vice versa.
- No threshold was applied for the results shown in Figure 5, as described correctly in the main text (Page 8). Figure 5 itself contained an error, stating that a cut-off of 0.1% was used. The corrected Table 1, Table 2 and Figure 5 are shown below.
The authors apologize for the errors and state that these do not change any scientific conclusions or interpretations of the data.
Haematologica | 109 July 2024
2379
Correspondence: N. Dworzak_Michael dworzak@stanna.at
Received: January 25, 2024. Accepted: January 25, 2024.
https://doi.org/10.3324/haematol.2024.285153
©2024 Ferrata Storti Foundation Published under a CC BY-NC license
Continued on following page.